Soleno Therapeutics Announces Presentation of DCCR Data at the 11th International Prader-Willi Syndrome Organisation Conference

11.07.2022 - REDWOOD CITY, Calif., July 11, 2022 (GLOBE NEWSWIRE) - Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced presentations at ... Seite 1

Related Keywords

Siri Bolding ,Adam Pittman ,Jenniferl Miller ,Casimir Inc ,Foundation For Prader Willi Research ,University Of Florida School Medicine ,International Prader Willi Syndrome Organisation Conference ,Folia Health ,International Prader Willi Syndrome Organisation ,Term Safety ,Diazoxide Choline Extended Release ,Florida School ,Characterize Efficacy ,Final Qualitative Interview ,Caregiver Participants ,Problem Behaviors ,Receiving Diazoxide Choline Extended Release ,Matched Participants ,Prader Willi Research ,Natural Language Processing ,